Mucosal healing effect of mesalazine granules in naproxen-induced small bowel enteropathy

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

535

HTML

4667

Figures (1-4)

245

Tables (1-3)

173

Sum=5620

Feb 14, 2013 (publication date) through Nov 4, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Feb 14, 2013; 19(6): 889-896
Published online Feb 14, 2013. doi: 10.3748/wjg.v19.i6.889

Table 1 Baseline characteristics of the intent-to-treat patient population (n = 10)

NA: Not available; NSAID: Non-steroidal anti-inflammatory drugs.

Citation: Rácz I, Szalai M, Kovács V, Regőczi H, Kiss G, Horváth Z. Mucosal healing effect of mesalazine granules in naproxen-induced small bowel enteropathy. World J Gastroenterol 2013; 19(6): 889-896
URL: https://www.wjgnet.com/1007-9327/full/v19/i6/889.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i6.889